GH

Guardant Health
NASDAQ
101.85
+3.49
+3.55%
After Hours: 101.45 -0.4 -0.39% 19:08 02/06 EST
OPEN
100.77
PREV CLOSE
98.36
HIGH
102.70
LOW
97.52
VOLUME
2.27M
TURNOVER
--
52 WEEK HIGH
120.74
52 WEEK LOW
34.88
MARKET CAP
13.12B
P/E (TTM)
-31.7003
1D
5D
1M
3M
1Y
5Y
1D
Cathie Wood ‘Buys the Dip’ in GOOGL Stock, Trims Coinbase (COIN) after 13% Rally
TipRanks · 1d ago
Guardant Reveal Study Spurs Fresh Look At Guardant Health Valuation Risks
Simply Wall St · 1d ago
Is Guardant Health (GH) Still Attractive After A 140% One Year Share Price Surge
Simply Wall St · 4d ago
Guardant Health nimmt an der Barclays Global Healthcare Conference in Miami Beach teil
Reuters · 5d ago
Guardant Health CtDNA Study Reshapes Colon Cancer Care And Investor Focus
Simply Wall St · 5d ago
Guardant reports publication of circulating tumor DNA for MRD detection study
TipRanks · 6d ago
Guardant Health Announces Publication Of Study To Date Evaluating Circulating Tumor DNA For MRD Detection In Patients With Resected Stage III Colon Cancer After Surgery And Before Adjuvant Chemotherapy
Benzinga · 6d ago
Guardant Reveal Blood Test Improves Recurrence Prediction in Stage III Colon Cancer Patients
Reuters · 6d ago
More
About GH
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Webull offers Guardant Health Inc stock information, including NASDAQ: GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.